🔎 Trials Near Me

Dachaigh › Diabaitis Seòrsa 2 › Nebraska

Sgrùdaidhean clionaigeach Diabaitis Seòrsa 2 ann an Nebraska

Tha 14 sgrùdaidhean airson Diabaitis Seòrsa 2 a’ lorg phàirtichean aig làraichean ann an Nebraska.

Bailtean ann an Nebraska

Teacsa sgrùdaidh oifigeil (Beurla)

EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease

  • Methodist Physicians Clinic, Fremont
  • Quality Clinical Research - Omaha, Omaha
A’ fastadhÌre 3
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 30 Sult 2026 · NCT07064473

A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events

  • Bryan Heart, Lincoln
A’ fastadhFàilte do shaor-thoilich fhallain
Aoisean 55 agus nas sine · Gach gnè · Air ùrachadh 28 Sult 2026 · NCT06112418

A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity

  • University Of Nebraska Medical Center, Omaha
A’ fastadhÌre 3
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 28 Sult 2026 · NCT07595549

A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight

  • Research Site, Omaha
  • Research Site, Omaha
A’ fastadhÌre 3
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 22 Sult 2026 · NCT07784270

Study to Assess the Effects of ALN-ANG3 in Adult Participants With Diabetic Kidney Disease

  • University of Nebraska Medical Center, Omaha
A’ fastadhÌre 2
Aoisean 18 gu 80 · Gach gnè · Air ùrachadh 11 Sult 2026 · NCT07271186

A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus

  • Research Site, Omaha
A’ fastadhÌre 3
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 9 Sult 2026 · NCT07662213

Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)

  • Velocity Clinical Research, Lincoln, Lincoln
  • Velocity Clinical Research, Omaha, Omaha
A’ fastadhÌre 2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 9 Sult 2026 · NCT07296484

A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus and Impaired Renal Function on Background Dapagliflozin

  • Research Site, Omaha
A’ fastadhÌre 3
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 2 Sult 2026 · NCT07662135

AMBITION 7: A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Insulin Glargine in People With Type 2 Diabetes and Increased Risk of Diseases That Affect the Heart and Blood Vessels Treated With 1-3 Other Diabetes Medications

  • Methodist Phys. Clinic, Omaha
A’ fastadhÌre 3
Aoisean 45 agus nas sine · Gach gnè · Air ùrachadh 1 Sult 2026 · NCT07797335

A Phase III Study to Investigate the Efficacy and Safety of the Combination of Elecoglipron and Dapagliflozin in Adults With Type 2 Diabetes Mellitus

  • Research Site, Elkhorn
A’ fastadhÌre 3
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 31 Lùna 2026 · NCT07662109

Study to Evaluate HM15275 in Subjects With Type 2 Diabetes Mellitus

  • Methodist Physicians Clinic, Fremont
A’ fastadhÌre 2
Aoisean 18 gu 75 · Gach gnè · Air ùrachadh 17 Lùna 2026 · NCT07527650

HP-211 Safety and Proof of Concept Dose Ranging Study in Patients With Type 2 Diabetes

  • Velocity Clinical Research Norfolk, Norfolk
A’ fastadhÌre 2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 23 Gibl 2026 · NCT07546929

Blood Markers of Early Pancreas Cancer

  • Unversity of Nebraska Medical Center, Omaha
A’ fastadhSgrùdadh amharcFàilte do shaor-thoilich fhallain
Aoisean 19 agus nas sine · Gach gnè · Air ùrachadh 2 Gearr 2026 · NCT03568630

SCS for Patient With Painful Diabetic Neuropathy and Peripheral Arterial Disease

  • University of Nebraska Medical Center, Omaha
A’ fastadh
Aoisean 19 gu 89 · Gach gnè · Air ùrachadh 22 Dàmh 2025 · NCT06480786

Bho ClinicalTrials.gov, dàta air a thogail 5 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.